Lannett Company, Inc.
(NYSE : LCI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.34%140.440.6%$757.55m
PFEPfizer Inc.
0.48%43.220.9%$741.35m
MRKMerck & Co., Inc.
-0.35%70.180.6%$454.80m
ABBVAbbVie, Inc.
0.02%95.392.1%$342.70m
LLYEli Lilly and Company
0.47%106.211.0%$321.44m
BMYBristol-Myers Squibb Company
0.08%61.351.4%$269.86m
AZNAstraZeneca PLC Sponsored ADR
-0.56%37.351.3%$130.36m
NVSNovartis AG Sponsored ADR
-0.56%84.650.2%$110.19m
GSKGlaxoSmithKline plc Sponsored ADR
0.13%39.260.2%$72.96m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.57%47.370.1%$52.43m
SNYSanofi Sponsored ADR
-0.27%43.630.2%$44.01m
LCILannett Company, Inc.
-1.53%4.8337.0%$15.58m
AKTXAkari Therapeutics Plc Sponsored ADR
1.57%2.071.7%$0.13m
EPIXESSA Pharma Inc
3.81%3.270.1%$0.05m

Company Profile

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. Its products include aqueous vitamin D 4; escltalopram oxalate; renitidine syrup; danazol; primidone; and isonlazid. The company was founded in 1942 and is headquartered in Philadelphia, PA.